Peer-Reviewed Publication
Tech Coloproctol2026;30(1)May 14, 2026Journal Article

Use of artificial intelligence in analysis of endoscopic images to detect residual disease or regrowth in rectal patients with complete clinical response to neoadjuvant chemoradiotherapy.

M A Javed1,2, M Mascarenhas3,4,5,6,7, F Mendes3,4,5,7, E Carvalho8, R Rajan9, A Santos5,7, Z Khan10, I Blake9,10, S Ahmed9,10
1Institute of Systems Molecular and Integrated Biology, The University of Liverpool, Liverpool, UK. ahsanj@liverpool.ac.uk.
2Department of Colorectal Surgery, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK. ahsanj@liverpool.ac.uk.
3Precision Medicine Unit, Department of Gastroenterology, Unidade Local de Saúde São João, Porto, Portugal.
4WGO Gastroenterology and Hepatology Training Center, Porto, Portugal.
5Faculty of Medicine, University of Porto, Porto, Portugal.
6CINTESIS-RISE, Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal.
7DigestAID, Digestive Artificial Intelligence Development, Porto, Portugal.
8INEGI, Instituto de Ciência E Inovação Em Engenharia Mecânica E Engenharia Industrial, Porto, Portugal.
9Institute of Systems Molecular and Integrated Biology, The University of Liverpool, Liverpool, UK.
10Department of Colorectal Surgery, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK.

Abstract

BACKGROUND: Patients with rectal cancer who have a complete clinical response (cCR) to neoadjuvant chemo/radiotherapy (nCRT) may opt for organ preservation and watch and wait (W&W). This consists of an intense surveillance program including serial endoscopies, pelvic magnetic resonance imaging (MRI), carcinoembryonic antigen (CEA), and computed tomography (CT) scans to detect regrowth at an early…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.